Chan Kin Foong 4
4 · BioPharmX Corp · Filed Dec 22, 2017
Insider Transaction Report
Form 4
BioPharmX CorpBPMX
Chan Kin Foong
10% Owner
Transactions
- Award
Employee Stock Option (right to buy)
2017-12-20+414,000→ 414,000 totalExercise: $0.20Exp: 2027-12-20→ Common Stock (414,000 underlying) - Award
Employee Stock Option (right to buy)
2017-12-20+900,000→ 900,000 totalExercise: $0.10Exp: 2027-12-20→ Common Stock (900,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable ratably over 36 months